| Monday, June 23, 2025 Abstract Session 21 – CRS – Biologics 2 ROOM 10 (G7) | Level +1 15:00h – 16:15h ABSTRACTS |
| Chair: Josje Otten |
| 4149 – Distinct Response Patterns to Dupilumab in Severe CRSwNP: A 12-Month Latent Class Trajectory Analysis of Nasal Polyp Scores |
| Böscke Robert |
| 4563 – Switch to dupilumab from other biologic therapy in severe CRSwNP: a comparison with naïve patients |
| Lucidi Daniela |
| 4403 – The clinical applications of biologics in extensive allergic fungal sinusitis |
| Almomen Ali |
| 3841 – Dupilumab Real-World Effectiveness in Surgery-Naïve and Previous Surgery Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from the Global AROMA Registry |
| Cornet Marjolein E. |
| 3942 – The role of Eotaxin-3 in the recurrence of Chronic Rhinosinusitis with Nasal Polyps |
| Florean Delia |
| 3943 – Efficacy of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Evaluating Biweekly and Monthly Dosing Strategies |
| Kana Martin |
| 4025 – Monoclonal Antibodies significantly improve Symptoms of Aspirin-Exacerbated Respiratory disease |
| Knudsen Marie |
| 4552 – Correlation of baseline eosinophil cell counts and baseline serum total IgE level with olfactory improvement and nasal polyp scores in CRSwNP patients during dupilumab treatment |
| Forgács Gábor |
